We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
-13.79%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$60.7B
AUM Growth
-$3.86B
Cap. Flow
+$5.72B
Cap. Flow %
9.42%
Top 10 Hldgs %
45.78%
Holding
2,623
New
243
Increased
1,351
Reduced
530
Closed
342

Sector Composition

Rank Sector Weight
1 Technology 4.52%
2 Financials 3.01%
3 Healthcare 1.66%
4 Consumer Discretionary 1.56%
5 Consumer Staples 1.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLXP
2026
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$61K ﹤0.01%
25,000
STON
2027
DELISTED
StoneMor Inc.
STON
$61K ﹤0.01%
17,781
IAF
2028
abrdn Australia Equity Fund
IAF
$120M
$60K ﹤0.01%
4,302
+166
+4% +$2.74K
JOBY icon
2029
Joby Aviation
JOBY
$6.82B
$60K ﹤0.01%
+12,131
New +$63.9K
MRKR icon
2030
Marker Therapeutics
MRKR
$20.3M
$60K ﹤0.01%
18,164
+660
+4% +$2.19K
GRTS
2031
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$60K ﹤0.01%
24,950
+738
+3% +$1.94K
AIRS icon
2032
AirSculpt Technologies
AIRS
$325M
$59K ﹤0.01%
10,000
CNDT icon
2033
Conduent
CNDT
$230M
$59K ﹤0.01%
13,621
+1,001
+8% +$5.03K
FOSL icon
2034
Fossil Group
FOSL
$239M
$59K ﹤0.01%
+11,503
New +$93.1K
OPEN icon
2035
Opendoor
OPEN
$3.69B
$59K ﹤0.01%
12,921
+2,136
+20% +$14.1K
RDHL
2036
Redhill Biopharma
RDHL
$3.85M
$59K ﹤0.01%
68
BNOV icon
2037
Innovator US Equity Buffer ETF November
BNOV
$208M
$58K ﹤0.01%
+2,015
New +$60.6K
HL icon
2038
Hecla Mining
HL
$10.2B
$57K ﹤0.01%
14,623
-4,196
-22% -$21.8K
WKHS icon
2039
Workhorse Group
WKHS
$29.5M
$57K ﹤0.01%
7
+2
+40% +$18.9K
META icon
2040
CALL
Meta Platforms (Facebook)
META
$1.51T
$55K ﹤0.01%
+2,900
New +$559K
AMED
2041
DELISTED
Amedisys
AMED
$53K ﹤0.01%
506
-1,377
-73% -$176K
GRWG icon
2042
GrowGeneration
GRWG
$82.9M
$53K ﹤0.01%
+14,646
New +$83.5K
REAX icon
2043
Real Brokerage
REAX
$368M
$53K ﹤0.01%
35,015
-27,504
-44% -$46.6K
CRBP icon
2044
Corbus Pharmaceuticals
CRBP
$170M
$52K ﹤0.01%
6,901
ITUB icon
2045
Itaú Unibanco
ITUB
$91.3B
$52K ﹤0.01%
13,832
+22
+0.2% +$98
KPTI icon
2046
Karyopharm Therapeutics
KPTI
$168M
$52K ﹤0.01%
773
-100
-11% -$9.17K
MOMO
2047
Hello Group
MOMO
$869M
$52K ﹤0.01%
+10,345
New +$54.2K
PSTX
2048
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$52K ﹤0.01%
20,304
-1,169
-5% -$3.25K
CTSO icon
2049
Cytosorbents Corp
CTSO
$22.6M
$51K ﹤0.01%
23,415
+2,120
+10% +$4.87K
HIO
2050
Western Asset High Income Opportunity Fund
HIO
$335M
$51K ﹤0.01%
+12,840
New +$53.6K

Similar funds

Creative Planning's Q2 2022 Portfolio in Review

As of Q2 2022, Creative Planning held 2,623 positions worth $60.7B, down 6% from $64.6B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Creative Planning deployed $5.72B of net new capital in Q2 2022, opening 243 new positions and adding to 1,351 existing holdings. Its largest new stake was Dimensional US Marketwide Value ETF: 2,518,817 shares worth $79.6M.

By sector, the portfolio is most concentrated in Technology at 4.5% of assets, down from 4.8% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard Total Bond Market, an estimated $379M trimmed.

  • Creative Planning's largest Q2 2022 buy was Dimensional US Marketwide Value ETF: 2,518,817 shares worth $79.6M.
  • Creative Planning added most to iShares Core S&P 500 ETF in Q2 2022, an estimated $1B increase.
  • Creative Planning's biggest Q2 2022 reduction was Vanguard Total Bond Market, cutting an estimated $379M.
  • Creative Planning fully exited CVB Financial in Q2 2022, selling an estimated $27.2M.
  • Creative Planning's ten largest holdings make up 46% of its $60.7B portfolio in Q2 2022.
  • Creative Planning opened 243 new positions and closed 342 in Q2 2022.
  • Creative Planning's portfolio value fell 6% quarter-over-quarter to $60.7B.

Based on Creative Planning's 13F filing for Q2 2022, filed 15 Aug 2022.